Index of reports
> Serious Events (1955)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine serious events. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 1955 Next >>
Possible Cytarabine side effects in female
Reported by a physician from Japan on 2012-08-27
Patient: female, weighing 45.8 kg (100.8 pounds)
Reactions: Cerebral Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-12
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Ofatumumab
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-08
Other drugs received by patient: Granisetron; Maglax; Primperan TAB; Rabeprazole Sodium; Orgadrone
Possible Cytarabine side effects in 10 year old male
Reported by a physician from United States on 2012-08-27
Patient: 10 year old male, weighing 76.1 kg (167.4 pounds)
Reactions: Hypersensitivity, Hyperglycaemia, Peripheral Motor Neuropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Cytarabine
Dosage: 75mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Mercaptopurine
Dosage: 60mgm2 cyclic
Administration route: Oral
Indication: T-Cell Type Acute Leukaemia
Methotrexate
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-06
Nelarabine
Dosage: 650mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-05-22
PEG-Asparaginase
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2012-06-13
Other drugs received by patient: Radiation
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-27
Patient: male, weighing 87.0 kg (191.4 pounds)
Reactions: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Start date: 2012-05-16
Cytarabine
Start date: 2012-05-16
Daunorubicin HCL
Start date: 2012-05-16
Daunorubicin HCL
Start date: 2012-05-16
Revlimid
Administration route: Oral
Start date: 2012-05-16
End date: 2012-05-31
Other drugs received by patient: Fluconazole; Ciprofloxacin HCL
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-27
Patient: female, weighing 67.6 kg (148.7 pounds)
Reactions: Nodule, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 90 mg, unk, 1 hr infusion on d2,d4,d6,d8,d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-01
Cytarabine
Dosage: 1.80 g, unk,continuous infusion d1 to d10
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Idarubicin HCL
Dosage: 48 mg, unk, on d1,d3,d5
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Other drugs received by patient: Fluconazole; Valaciclovir; Ceftazidime; Oxazepam; Leucoplenin
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-24
Patient:
Reactions: Radiculopathy
Drug(s) suspected as cause:
Cisplatin
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: Memory Impairment
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amphotericin B
Dosage: 6x60 mg/d
Administration route: Oral
Start date: 2012-06-24
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Cytarabine
Dosage: 110 mg, per day
Start date: 2012-08-16
Furosemide
Dosage: 2x10mg/d
Start date: 2012-08-09
End date: 2012-08-11
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-08
End date: 2012-08-11
Granisetron
Dosage: 3 mg, per day
Start date: 2012-08-16
Imatinib Mesylate
Dosage: 450 mg, per day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
Mercaptopurine
Dosage: 1x87.5mg/d average
Administration route: Oral
Start date: 2012-08-06
Pantoprazole
Dosage: 40 mg, per day
Administration route: Oral
Start date: 2012-06-24
End date: 2012-08-15
Sulfamethoxazole and Trimethoprim
Dosage: 2x120mg every sat, sun and mon
Administration route: Oral
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Dexamethasone
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-24
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Subdural Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: 430 milligram
Start date: 2012-08-14
End date: 2012-08-19
Daunorubicin HCL
Start date: 2012-08-14
End date: 2012-08-16
Revlimid
Dosage: 20 milligram
Administration route: Oral
Start date: 2012-08-14
End date: 2012-08-19
Other drugs received by patient: Fraxiparine
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in 17 year old male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Dyspnoea, Tachycardia, Atrial Fibrillation, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1470 mg
Start date: 2012-08-10
Daunorubicin HCL
Dosage: 570 mg
End date: 2012-08-06
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient:
Reactions: Cardio-Respiratory Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-02-21
End date: 2012-02-21
Emend
Dosage: 80 mg, once
Administration route: Oral
Start date: 2012-02-22
End date: 2012-02-22
Etoposide
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 160 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 60 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Other drugs received by patient: Bicnu; Diamicron; Pravastatin Sodium; Amlodipine; Valium; Nexium; Tramadol HCL; Acetaminophen
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-21
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-17
End date: 2012-07-20
Dasatinib
Dosage: 40 milligram daily;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-29
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
End date: 2012-07-21
Other drugs received by patient: Zofran; Miralax
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-22
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Confusional State, Hepatic Enzyme Abnormal, Disorientation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 57 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-06
Cytarabine
Dosage: 360 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-28
Etoposide
Dosage: 212 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-28
Methotrexate
Dosage: 900 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-31
Methotrexate
Dosage: 15 mg, unk
Start date: 2012-08-06
Prednisolone
Dosage: 55 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-06
Other drugs received by patient: Esomeprazole Sodium; Oxazepam; Fluconazole
Possible Cytarabine side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22
Patient: 54 year old female
Reactions: Osteomyelitis, Febrile Neutropenia, Osteonecrosis, Bacterial Disease Carrier, Face Oedema, Osteonecrosis of JAW, Endocarditis Enterococcal, Bone Marrow Failure, Candidiasis, Purulent Discharge, Pain in JAW
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 3 g/m2 every 12 hours for 4 days
Daunorubicin HCL
Dosage: 45 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Pain in Extremity, Hypotension, Splenic Infarction, Paraesthesia, Septic Embolus, Fungal Test Positive, Hypoxia, Circulatory Collapse, Asthenia, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, intrathecal
End date: 2012-07-12
Daunorubicin HCL
Dosage: 200 mg
End date: 2012-08-02
Methotrexate
Dosage: 30 m, intrathecal
End date: 2012-08-09
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 4900 iu, intravenous
End date: 2012-07-15
Prednisone
Dosage: 3360 mg, oral
Administration route: Oral
End date: 2012-08-08
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-22
Patient: female, weighing 23.6 kg (51.9 pounds)
Reactions: Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Decreased, RED Blood Cell Schistocytes Present, Fibrin D Dimer Increased, International Normalised Ratio Increased, Coagulopathy, Prothrombin Time Prolonged
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg
Daunorubicin HCL
Dosage: 46 mg
Dexamethasone
Dosage: 115 mg
Methotrexate
Dosage: 12 mg
PEG-L Asparaginase (Pegaspargase, Oncospar)
Vincristine Sulfate
Dosage: 2.8 mg
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-21
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-08-21
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 mg, 2x/day
Indication: Medulloblastoma
Cytarabine
Dosage: 50 mg, cyclic, every other month
Cytarabine
Dosage: 50 mg, cyclic, every other week then monthly
Indication: Medulloblastoma
Etoposide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate
Possible Cytarabine side effects in 64 year old male
Reported by a physician from Germany on 2012-08-21
Patient: 64 year old male, weighing 105.5 kg (232.1 pounds)
Reactions: Multi-Organ Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 54.53 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-08
End date: 2012-08-11
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Meropenem
Possible Cytarabine side effects in male
Reported by a physician from United Kingdom on 2012-08-21
Patient: male, weighing 80.9 kg (178.0 pounds)
Reactions: Lower Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-09
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-09
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-08
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-08-08
Other drugs received by patient: Perindopril Erbumine; Aspirin; Persantine
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Cytarabine side effects in male
Reported by a physician from United States on 2012-08-21
Patient: male, weighing 13.6 kg (29.9 pounds)
Reactions: Contusion, Vomiting, Flatulence, Hypotension, Tachycardia, Gastrointestinal Necrosis, Cardio-Respiratory Arrest, Hypophagia, Abdominal Distension, Bacterial Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: it 2-2.99 yrs 50 mg
Dexamethasone TAB
Dosage: po 3 mg/m2 dose (1.75 bid)
Administration route: Oral
Methotrexate Sodium
Dosage: it 2 mg/m2
PEG-L Asparaginase (Pegaspaegase, Oncospar)
Dosage: iv 2500 units/m2
Vincristine
Dosage: iv 1.5mg/m2 on day 1 and day 8
Possible Cytarabine side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-08-21
Patient: 8 year old female
Reactions: Mucoepidermoid Carcinoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-08-21
Patient: 51 year old female
Reactions: Granulocytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Staphylococcal Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 40 mg/m2, qd
Indication: Acute Myeloid Leukaemia Recurrent
Cytarabine
Dosage: 1 g/m2, qd
Indication: Acute Myeloid Leukaemia Recurrent
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Adrenal Insufficiency, Encephalopathy
Drug(s) suspected as cause:
Cytarabine
Dosage: unk unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Page 1 Next >>
|